Utilizing Hysteroscopic Mesh Resection for Presacral Mesh Infection Following Sacrocolpopexy

This study assessed the feasibility and efficacy of hysteroscopic mesh resection in managing presacral mesh infection following sacrocolpopexy. A retrospective analysis was conducted on three cases of presacral mesh infection treated with hysteroscopic total mesh resection between January 2020 and December 2021. The cases were classified and diagnosed using category-time-site (CTS) coding for complications, and perioperative indicators were evaluated. The mean age of the patients was 61.67 years (SD 4.44). Surgical time averaged 37.33 min (SD 5.11), with an intraoperative bleeding volume of 13.33 ml (SD 4.44). The hospitalization cost was 12,436.43 yuan (SD 2281.79), and the postoperative hospitalization duration was 6.25 days (SD 0.88). The preoperative frailty index was 0.18 in two out of three cases, indicating favorable surgical tolerance. There were no 30-day unplanned readmissions. At 3 months post-operation, the Patient Global Impression of Improvement (PGI-I) score was 100%, indicating good outcomes with a subjective cure rate of 100%. These findings indicate that hysteroscopic mesh resection could be a viable and effective treatment modality for presacral mesh infection following sacrocolpopexy.